Skip to content
Unrated Medical device recall · FDA · Published June 10, 2021

Mercedes Medical Lingen SAMPLE Virus Sampling Kit Recalled Due to No FDA Clearance

Mercedes Medical recalls Lingen SAMPLE Disposable Virus Sampling Kits with no FDA 510(k) clearance. Affected kits may not be safe for medical use. Consumers should contact the company for details.

🇺🇸 FDA recall #Z-2067-2021Medical deviceMercedes Medical ›
Take action

Contact the company

Recalling firmMercedes Medical, Inc.12210 Rangeland Parkway · Lakewood Ranch, FL 34211
✎ GovInfoNow plain-language explainer

What happened, in plain English

Mercedes Medical is recalling Lingen SAMPLE Disposable Virus Sampling Kits that lack FDA 510(k) clearance. This means the kits may not be safe for medical use, potentially leading to health risks if used improperly. Read more at govinfonow.com/recall/62356-mercedes-medical-lingen-sample-virus-sampling-kit-recalled-due-to.

Source Summary by GovInfoNow · govinfonow.com/recall/62356-mercedes-medical-lingen-sample-virus-sampling-kit-recalled-due-to · Updated August 19, 2026 · FDA enforcement record: FDA #Z-2067-2021

Cite this page

“Mercedes Medical Lingen SAMPLE Virus Sampling Kit Recalled Due to No FDA Clearance.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/62356-mercedes-medical-lingen-sample-virus-sampling-kit-recalled-due-to. Based on FDA recall #Z-2067-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2067-2021%22&limit=1).

Why it’s dangerous

The kits lack FDA 510(k) clearance, meaning they have not been approved for medical use. This could lead to improper testing results or health risks if used without proper safety standards.

Who’s affected

Healthcare workers and individuals using these kits for virus testing may be affected. Those with the specific model numbers and lots are most at risk.

How to tell if you have this one

Check for the model numbers SAM ENI MTM-04 or SAM ENI MTM04TUBE on the packaging. The kits contain 2 tubes and 2 swabs or 1 tube per pack.

  • Brand
    Mercedes Medical
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Worldwide distribution - US Nationwide distribution including in the states of Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Iowa, Idaho, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Missouri, Montana, North Carolina, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Pennsylvania, Texas, Virginia, Washington, Wisconsin, and Puerto Rico. The country of Bahamas. Government distribution was made but no military distribution.
Recall numberProduct, codes & lotsQuantity
Z-2066-2021Lingen Disposable Virus Sampling Kit, Item MTM-04, 40 tubes/box.; All lots.6,250 boxes MTM-04 with swab and 5,461 boxes MTM-04 tube only
Z-2067-2021Lingen SAMPLE Disposable Virus Sampling Kit pack, Item SAM ENI MTM-04, containing 2 tubes and 2 swabs/pack; and SAM ENI MTM04TUBE, containing 1 tube/pack.; All lots.SAM ENI MTM04 - 58 packs; and SAM ENI MTM04TUBE - 49 packs
Based on the official FDA remedy

What to do — step by step

  1. Contact Manufacturer

    Reach out to Mercedes Medical for specific instructions on how to handle the recalled kits.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 32 states.

Alaska: nationwideAKMaine: named in the noticeMEVermont: nationwideVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: nationwideORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: named in the noticeIAIndiana: nationwideINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: named in the noticeNCSouth Carolina: nationwideSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide distribution - US Nationwide distribution including in the states of Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Iowa, Idaho, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Maryland,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Puerto Rico, Texas, Virginia, Washington, Wisconsin.

Recall timeline

FDA terminated this recall 2.2 years after the firm started it.

1. Firm started the recall: Jun 10, 202112. FDA classified it Class II: Jul 12, 202123. Published in FDA’s Enforcement Report: Jul 21, 202134. FDA terminated the recall: Aug 14, 2023420212023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2067-2021 (June 10, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2067-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA